Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Ingevity Corporation (NGVT) Balance Sheet

As of 2026-06-30 (10-Q), Ingevity Corporation (NGVT) reported total assets of $1.5B, total liabilities of $1.5B and shareholders' equity of $46.9M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $97.4M. Long-term debt: $1.1B.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

NGVTIngevity CorporationFollow NGVT — free
Specialty Chemicals · Basic Materials
—
Price chart with a free account
Market cap
2.4B
P/E TTM
46.4
Dividend yield
—
52-week
—
Next earnings
4 Nov, in 11 days
LineFY2014
Dec 14
FY2016
Dec 16
FY2017
Dec 17
FY2018
Dec 18
FY2019
Dec 19
FY2020
Dec 20
FY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
Latest
Jun 26
Trend
Cash and equivalents0.020.030.090.080.060.260.280.080.100.070.080.10
Receivables—0.090.100.120.150.15——————
Inventory—0.150.160.190.210.190.240.340.310.200.190.15
Current assets—0.300.370.420.460.630.720.680.660.490.450.54
Total assets0.720.830.931.322.142.332.472.742.622.021.651.54
Current liabilities—0.140.150.180.220.220.270.300.360.260.340.34
Long-term debt—0.480.440.741.231.271.251.471.381.341.161.06
Short-term debt—0.010.010.010.020.030.020.000.080.060.050.14
Total liabilities—0.700.650.981.611.691.802.041.991.831.621.49
Shareholders' equity0.420.130.280.340.530.640.670.700.630.200.030.05

USD billions · SEC XBRL

Ingevity Corporation — questions

How much cash does Ingevity Corporation have?
$97.4M in cash and cash equivalents as of 2026-06-30.
How much debt does Ingevity Corporation have?
$1.1B of long-term debt and $144.0M due within a year as of 2026-06-30.
What are Ingevity Corporation's total assets?
$1.5B as of 2026-06-30.
What is Ingevity Corporation's shareholders' equity?
$46.9M as of 2026-06-30.

Every figure on this page comes from Ingevity Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.